Abstract
ADVANCING THE CLINICAL EVALUATION OF DAIVA-VYAPASHRAYA CHIKITSA: TOWARDS AN ADAPTED RCT FRAMEWORK

Dr. Ashish Kumar Gaur*, Dr. Vikas Bhardwaj

ABSTRACT

Randomized controlled trials (RCTs) are widely regarded as the strongest design for estimating causal effects. However, the conventional RCT model was developed mainly around interventions that can be standardized, dosed, delivered uniformly and, where possible, blinded. Daiva-vyapashraya Chikitsa presents a different methodological situation. It includes mantra, prayer, homa, fasting and other ritual or spiritual measures whose effects may depend on the practitioner, participant, setting, belief, expectation and manner of delivery. This review examines major limitations of conventional RCT methodology when applied to Daiva-vyapashraya Chikitsa, using methodological literature on non-pharmacological and complex interventions and selected trials of spiritual and mantra-based interventions. Major concerns are intervention heterogeneity, poor standardization, inability to blind participants and providers, difficulty developing credible sham controls, treatment-fidelity problems, expectancy and contextual effects, practitioner effects, outcome selection and tension between internal and external validity. RCTs remain useful, but they should be preceded by intervention development, feasibility work and process evaluation and should use methods adapted to complex non-pharmacological interventions.

Keywords: Daiva-vyapashraya Chikitsa, Ayurveda, randomized controlled trial, mantra, methodology, spiritual intervention.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: OCTOBER ISSUE PUBLISHED

    OCTOBER 2026 Issue has been successfully launched on 1 OCTOBER 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT